ISRG vs JPM: Which Is the Better Buy?
Side-by-side comparison of Intuitive Surgical, Inc. and JPMorgan Chase & Co. — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-25.
Intuitive Surgical, Inc. · Healthcare
$399.52
+22.4% upside to fair value
Med Conviction
Grade B
High Quality
VS
JPMorgan Chase & Co. · Financial Services
$350.13
+26.9% upside to fair value
Med Conviction
Grade A-
High Quality
QuantHub Verdict
JPM has more upside to fair value
(+26.9%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
ISRG |
JPM |
| Current Price |
$399.52 |
$350.13 |
| Fair Value Estimate |
$488.97 |
$444.48 |
| Upside to Fair Value |
+22.4%
|
+26.9%
|
| Market Cap |
$141.1B |
$938.2B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
30.7x
|
20.0x
|
| Price / Sales |
12.8x
|
3.1x
|
| Price / FCF |
44.0x
|
—
|
| Revenue Growth YoY |
+18.5%
|
+17.9%
|
| Gross Margin |
66.7%
|
62.6%
|
| Operating Margin |
31.3%
|
28.2%
|
| Return on Equity |
17.8%
|
17.8%
|
| Dividend Yield |
0% |
1.71% |
| FCF Yield |
2.28%
|
—
|
| Analyst Consensus |
Strong Buy
|
Buy
|
Investment Thesis
Intuitive Surgical develops, produces, and commercializes the da Vinci surgical system and the Ion endoluminal system, along with instruments, accessories, training, and digital solutions that drive a large installed-base and recurring-revenue model. Business quality is high: TTM gross margin of 66.7%, operating margin of 31.3%, net margin of 28.4%, ROE of 17.8%, and revenue growth of 18.5% with …
JPMorgan Chase is a diversified global bank spanning consumer banking, cards, payments, commercial banking, investment banking, markets, treasury services, and asset and wealth management, with an unusually high-quality franchise supported by funding scale, distribution, leading market positions and cross-selling across 86.6 million U.S. consumers and more than 90% of Fortune 500 companies. Busin…
Accumulation Zones
| Metric |
ISRG |
JPM |
| Zone Low |
$366.73 |
$333.36 |
| Zone High |
$415.62 |
$377.81 |
| In Buy Zone? |
Yes
|
Yes
|